arrow_back Back to App

Ending Tax Deductions for Direct-to-Consumer Drug Advertisements

This new law aims to eliminate tax deductions for direct-to-consumer drug advertising expenses. This means pharmaceutical companies will no longer be able to reduce their taxes by spending on ads on TV, radio, or the internet. The goal is to potentially decrease the volume of drug advertisements, which might change how citizens learn about available medications.
Key points
Pharmaceutical companies will lose the ability to deduct direct-to-consumer drug advertising costs from their taxes.
This change applies to advertisements in media like television, radio, internet, direct mail, and billboards.
Advertisements in journals and other periodicals will still be eligible for tax deductions.
The law will apply to expenses paid or incurred after its enactment date.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1785
Sponsor: Sen. Hawley, Josh [R-MO]
Process start date: 2025-05-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

No Handouts for Drug Advertisements Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1785.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-15.

What are the main provisions?

Key points include:

  • Pharmaceutical companies will lose the ability to deduct direct-to-consumer drug advertising costs from their taxes.
  • This change applies to advertisements in media like television, radio, internet, direct mail, and billboards.
  • Advertisements in journals and other periodicals will still be eligible for tax deductions.
  • The law will apply to expenses paid or incurred after its enactment date.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hawley, Josh [R-MO].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Taxes Health Media and Culture